Akosua Mireku

3 weeks ago | pharmaceutical-technology.com | Akosua Mireku

At the BioTrinity Conference, experts champion government funding programmes to bridge gaps in UK venture capital financing. Carmine Circelli described a growing gap between the British healthcare space and other global markets at the BioTrinity 2025 conference. Credit: Max Zolotukhin via Getty Images.

4 weeks ago | pharmaceutical-technology.com | Akosua Mireku

EU member states are set to launch the EU Health Data Space Regulation for harmonised data transfer on 26 March. An intellectual property lawyer discussed the implementation of the new EU Health Data Space Regulation and its effects on the EU healthcare market. Credit: mixmagic via Getty Images.

1 month ago | businessandamerica.com | Akosua Mireku

In recent years, major progress has been made in the development of gene therapies for rare diseases. However, research for some rare conditions, such as those due to inborn errors of metabolism, is stagnating due to logistical issues. The inborn errors of metabolism is a group of rare genetic disorders in which the body is unable to correctly metabolise food, typically due to some enzyme defects.

1 month ago | pharmaceutical-technology.com | Akosua Mireku

As Rare Disease Day is commemorated on 28 February, experts discuss the barriers to gene therapy access for some rare diseases. Ahead of rare disease day, experts discussed the barriers to gene therapy development for the inborn errors of metabolism. Credit: itakdalee via Shutterstock In recent years, major progress has been made in the development of gene therapies for rare diseases.

2 months ago | pharmaceutical-technology.com | Akosua Mireku

New EU regulations aim to speed up health technology assessments (HTAs), but the pharma industry raises logistical concerns. On 12 January, the EMA implemented the revamped EU HTA regulation for the assessment of cancer therapies and cell and gene therapies. Credit: Vepar5 via Getty Images Amid a wave of healthcare regulatory changes in the EU, an update on health technology assessment (HTA) regulation is set to speed up drug access times.